Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently ...
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback